agilon health (NYSE:AGL) Sees Unusually-High Trading Volume – Should You Buy?

agilon health, inc. (NYSE:AGL) shares saw unusually-strong trading volume on Tuesday . Approximately 6,150,804 shares changed hands during trading, an increase of 27% from the previous session’s volume of 4,856,478 shares.The stock last traded at $3.45 and had previously closed at $3.42.

Wall Street Analyst Weigh In

Several research firms have recently commented on AGL. Stifel Nicolaus reduced their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. TD Cowen reduced their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Barclays lowered their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Sanford C. Bernstein boosted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Finally, Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and upped their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $4.03.

agilon health Trading Up 0.8 %

The company’s 50 day simple moving average is $2.74 and its 200 day simple moving average is $3.12. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of -3.67 and a beta of 0.67.

Insider Buying and Selling

In other news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the purchase, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock valued at $198,100 in the last three months. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of agilon health

A number of institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC lifted its position in shares of agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after buying an additional 112,241 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares in the last quarter. Geode Capital Management LLC grew its position in shares of agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the last quarter. Finally, State Street Corp raised its stake in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.